Electra short interest hits 1.1% of shares
Alpha Vantage · MarketBeat · · AI-summarised by FinFlash
Electra Therapeutics (NASDAQ:ETRA) reported short interest of 702,266 shares in September, equal to 1.1% of shares sold short. The stock recently traded up 6.7%, and analysts hold multiple buy and outperform ratings with an average target price of $34.00. Two directors also increased their ownership by over 35%.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.